Neuren Pharmaceuticals LimitedASX: NEU

Neuren Pharmaceuticals: Half Yearly Report and Accounts 30 June 2015

· Issued by Neuren Pharmaceuticals Limited

Filed with ASX · · 14 pages · English

Neuren Pharmaceuticals Limited (“Neuren” or the “Company”) presents this financial report, including the interim consolidated financial statements, for the six months ended 30 June 2015, with the six months ended 30 June 2014 as the comparative period. 2. Results for announcement to the market 2.6 Explanation of results: The consolidated net loss after tax increased from $4.7 million to $5.3 milli

Neuren Pharmaceuticals Limited on 6ix

In the deck